Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the fourth quarter of 2022.
In this edition, class actions gain an international flair, insurers have cures for COVID cases, and a remote presence is still a presence. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the fourth quarter.